FMO5 and acute kidney injury: While animal experimental studies have demonstrated APO’s renoprotective effects in both ischemic and nephrotoxic AKI, cell culture models have been instrumental in identifying the cellular targets and molecular pathways involved, particularly its inhibition of NADPH oxidase activity and modulation of ROS signaling.